6 Green Days In A Row: Edwards Lifesciences Stock Is Up 14%
Edwards Lifesciences (EW) stock has risen for 6 consecutive trading days, gaining 13.8% over that stretch. That added about $7.3 billion to the company’s market value, which now stands at about $60.3 billion. The stock closed at $104.71 on Monday, November 9, its highest close of the past year.
EW Versus The S&P 500
Returns for EW and the S&P 500 over the streak and the periods around it, all ending Monday, November 9 and including dividends:
| Return Period | EW | S&P 500 |
|---|---|---|
| 1 Day | 2.5% | 2.3% |
| 6 Days (Current Streak) | 13.8% | -0.4% |
| 1 Month (21 Trading Days) | 22.9% | -3.3% |
| 3 Months (63 Trading Days) | 11.8% | -2.1% |
| Year To Date | 22.8% | 11.3% |
| 1 Year (252 Trading Days) | 27.0% | 13.7% |
A Stock-Specific Run, Or A Market Move?
The market explains little of this: the S&P 500 lost 0.4% over the same 6 sessions, including dividends, against Edwards Lifesciences’ +13.8%. 3 other S&P 500 stocks are currently on winning streaks of 6 days or longer. Over the past three months the stock is up 11.8%, a window that includes the streak; over the other 57 sessions of that window it was essentially flat (-1.8%).
What The Numbers Say About The Rally
On the fundamentals, revenue grew 13.4% over the last twelve months, against a median of 7.9% for S&P 500 Health Care stocks; its operating margin is 28.8%, versus a median of 17.4%; and the stock trades at 59.1 times trailing earnings against a median of 32.9. The numbers make the run harder to justify: a multiple well above the median. At this price, the stock is asking a lot of the business.
A climb like this is worth respecting, and worth testing. Our Guidance Momentum screen tracks the stocks whose companies just raised their own forward numbers.
Streaks End. Discipline Compounds
A run like this is genuinely useful information: something about this business has the market’s full attention. But streaks are where discipline gets tested, because the urge to chase strength is strongest right before it pauses.
The Trefis High Quality (HQ) Portfolio channels that urge into a system: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules rather than excitement. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Enjoy the streak; own the process.